and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).[2][edit] Combination avapro weight loss diureticIrbesartan is avapro weight loss available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an additive antihypertensive effect.

(2001). "Renoprotective effect of the angiotensin-receptor avapro weight loss irbesartan in patients avapro weight loss nephropathy due to type 2 diabetes.". N avapro weight loss J Med 345 (12): 851-60. PMID 11565517.^ Rossi avapro weight loss editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from Avapro)Jump to: navigation, searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status avapro weight loss (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan avapro weight loss (pronounced /?rb??s?rt?n/) is an angiotensin is.

for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis).